Indacaterol/ Glycopyrronium in Symptomatic Patients with COPD (GOLD 2 and GOLD 3) Versus Salmeterol/ Fluticasone. (2025). Indus Journal of Bioscience Research, 3(4), 614-617. https://doi.org/10.70749/ijbr.v3i4.859